# Vascular Endothelial Dysfunction in Sleep Apnea

> **NCT05289063** · PHASE1 · RECRUITING · sponsor: **Columbia University** · enrollment: 110 (estimated)

## Conditions studied

- Obstructive Sleep Apnea of Adult

## Interventions

- **DRUG:** Atorvastatin 10mg
- **DRUG:** Placebo
- **OTHER:** Continuous Positive Airway Pressure Therapy

## Key facts

- **NCT ID:** NCT05289063
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-03
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05289063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05289063, "Vascular Endothelial Dysfunction in Sleep Apnea". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05289063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*